These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2396304)

  • 1. The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients.
    Tortorice KL; Heim-Duthoy KL; Awni WM; Rao KV; Kasiske BL
    Ther Drug Monit; 1990 Jul; 12(4):321-8. PubMed ID: 2396304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity.
    Hammoud SH; Alkhansa S; Mahjoub N; Omar AG; El-Mas MM; Eid AA
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F572-F582. PubMed ID: 29767558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
    Leonetti G; Cuspidi C; Sampieri L; Terzoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S319-24. PubMed ID: 6184561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil.
    Dawidson I; Rooth P; Fry WR; Sandor Z; Willms C; Coorpender L; Alway C; Reisch J
    Transplantation; 1989 Oct; 48(4):575-80. PubMed ID: 2678635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP4A/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats.
    Hammoud SH; Omar AG; Eid AA; El-Mas MM
    Toxicol Appl Pharmacol; 2017 Nov; 334():110-119. PubMed ID: 28899749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of the interaction between cyclosporine and the calcium channel blocker nicardipine in renal transplant patients.
    Cantarovich M; Hiesse C; Lockiec F; Charpentier B; Fries D
    Clin Nephrol; 1987 Oct; 28(4):190-3. PubMed ID: 3319309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A--calcium channels interaction: a possible mechanism for nephrotoxicity.
    Nagineni CN; Misra BC; Lee DB; Yanagawa N
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1358-62. PubMed ID: 3824499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcium-channel blockers on renal function in renal-graft recipients treated with cyclosporine.
    Hauser AC; Derfler K; Stockenhuber F; Wamser P; Marosi L; Balcke P
    N Engl J Med; 1991 May; 324(21):1517. PubMed ID: 2023618
    [No Abstract]   [Full Text] [Related]  

  • 10. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
    Asberg A; Christensen H; Hartmann A; Berg KJ
    Clin Transplant; 1998 Oct; 12(5):363-70. PubMed ID: 9787942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients.
    Sketris IS; Methot ME; Nicol D; Belitsky P; Knox MG
    Ann Pharmacother; 1994 Nov; 28(11):1227-31. PubMed ID: 7849332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nifedipine in cyclosporine-induced nephrotoxicity in rats: roles of the thromboxane and endothelin systems.
    Darlametsos IE; Papanikolaou EN; Varonos DD
    Prostaglandins Leukot Essent Fatty Acids; 2000 Nov; 63(5):263-9. PubMed ID: 11090252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A; Druskis V; Laurinavicius A
    Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of calcium channel blockers on cyclosporine A (Cs A) induced nephrotoxicity in rats.
    Zima T; Nĕmecek K; Hátle K; Bártová V; Stípek S
    Sb Lek; 1995; 96(1):15-21. PubMed ID: 8711361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of calcium antagonists on hemodynamics and cyclosporine pharmacokinetics in heart-transplant and kidney-transplant patients.
    Roy LF; East DS; Browning FM; Shaw D; Ogilvie RI; Cardella C; Leenen FH
    Clin Pharmacol Ther; 1989 Dec; 46(6):657-67. PubMed ID: 2689045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism.
    Awni WM; Kasiske BL; Heim-Duthoy K; Rao KV
    Clin Pharmacol Ther; 1989 Jan; 45(1):41-8. PubMed ID: 2642778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral health in renal transplant recipients administered cyclosporin A or tacrolimus.
    Spolidorio LC; Spolidorio DM; Massucato EM; Neppelenbroek KH; Campanha NH; Sanches MH
    Oral Dis; 2006 May; 12(3):309-14. PubMed ID: 16700742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine pharmacokinetics in anti-HCV+ patients.
    Wolffenbüttel L; Poli DD; Manfro RC; Gonçalves LF
    Clin Transplant; 2004 Dec; 18(6):654-60. PubMed ID: 15516239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the natriuretic hormone in the action of nifedipine and verapamil on the kidneys].
    Filipets ND
    Eksp Klin Farmakol; 1997; 60(1):40-1. PubMed ID: 9162282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.